Dynamic Technology Lab Private Ltd Makes New $918,000 Investment in Ingevity Co. (NYSE:NGVT)

Dynamic Technology Lab Private Ltd acquired a new stake in Ingevity Co. (NYSE:NGVT - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 23,530 shares of the company's stock, valued at approximately $918,000. Dynamic Technology Lab Private Ltd owned 0.06% of Ingevity at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Ingevity by 2.0% during the first quarter. Vanguard Group Inc. now owns 3,818,520 shares of the company's stock worth $182,143,000 after buying an additional 75,198 shares during the period. Thrivent Financial for Lutherans boosted its stake in Ingevity by 1.7% during the third quarter. Thrivent Financial for Lutherans now owns 1,383,053 shares of the company's stock worth $53,939,000 after buying an additional 23,497 shares during the period. Segall Bryant & Hamill LLC boosted its stake in Ingevity by 33.5% during the third quarter. Segall Bryant & Hamill LLC now owns 1,185,415 shares of the company's stock worth $46,231,000 after buying an additional 297,135 shares during the period. Victory Capital Management Inc. boosted its stake in Ingevity by 1.4% during the second quarter. Victory Capital Management Inc. now owns 1,028,685 shares of the company's stock worth $44,964,000 after buying an additional 13,771 shares during the period. Finally, Royce & Associates LP boosted its stake in Ingevity by 23.3% during the third quarter. Royce & Associates LP now owns 933,677 shares of the company's stock worth $36,413,000 after buying an additional 176,447 shares during the period. Hedge funds and other institutional investors own 91.59% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on NGVT shares. BMO Capital Markets increased their price target on shares of Ingevity from $40.00 to $47.00 and gave the stock a "market perform" rating in a research report on Thursday, October 31st. CJS Securities raised shares of Ingevity from a "market perform" rating to an "outperform" rating and set a $58.00 price target on the stock in a research report on Wednesday, August 7th. Wells Fargo & Company reduced their price target on shares of Ingevity from $45.00 to $40.00 and set an "equal weight" rating on the stock in a research report on Monday, August 5th. Finally, Oppenheimer reduced their price target on shares of Ingevity from $58.00 to $50.00 and set an "outperform" rating on the stock in a research report on Thursday, August 1st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $52.17.

Ingevity Stock Up 0.5 %

NYSE:NGVT traded up $0.22 during mid-day trading on Thursday, hitting $47.73. The stock had a trading volume of 181,636 shares, compared to its average volume of 267,883. The stock has a 50-day simple moving average of $40.15 and a two-hundred day simple moving average of $41.89. The company has a market capitalization of $1.73 billion, a PE ratio of -3.07 and a beta of 1.60. Ingevity Co. has a twelve month low of $30.90 and a twelve month high of $56.29. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 6.52.

Ingevity (NYSE:NGVT - Get Free Report) last issued its earnings results on Tuesday, October 29th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.50. The firm had revenue of $376.90 million for the quarter, compared to analysts' expectations of $376.95 million. Ingevity had a negative net margin of 38.11% and a positive return on equity of 24.46%. The firm's revenue was down 15.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.21 earnings per share. On average, equities research analysts anticipate that Ingevity Co. will post 2.55 EPS for the current year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.